MeSH Review:
Renal Dialysis
- The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. Ifudu, O., Feldman, J., Friedman, E.A. N. Engl. J. Med. (1996)
- Effect of the dialysis membrane in the treatment of patients with acute renal failure. Hakim, R.M., Wingard, R.L., Parker, R.A. N. Engl. J. Med. (1994)
- Conjugated estrogens for the management of bleeding associated with renal failure. Livio, M., Mannucci, P.M., Viganò, G., Mingardi, G., Lombardi, R., Mecca, G., Remuzzi, G. N. Engl. J. Med. (1986)
- Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis. Goldberg, A.P., Applebaum-Bowden, D.M., Bierman, E.L., Hazzard, W.R., Haas, L.B., Sherrard, D.J., Brunzell, J.D., Huttunen, J.K., Ehnholm, C., Nikkila, E.A. N. Engl. J. Med. (1979)
- Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. Arnaout, M.A., Hakim, R.M., Todd, R.F., Dana, N., Colten, H.R. N. Engl. J. Med. (1985)
- Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk--The Study of Osteoporotic Fractures. Cauley, J.A., Zmuda, J.M., Yaffe, K., Kuller, L.H., Ferrell, R.E., Wisniewski, S.R., Cummings, S.R. J. Bone Miner. Res. (1999)
- Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity. Sprague, S.M., Corwin, H.L., Wilson, R.S., Mayor, G.H., Tanner, C.M. Arch. Intern. Med. (1986)
- Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Ifudu, O., Paul, H., Mayers, J.D., Cohen, L.S., Brezsnyak, W.F., Herman, A.I., Avram, M.M., Friedman, E.A. Am. J. Kidney Dis. (1994)
- Calcification of the epididymis and the tunica albuginea of the corpora cavernosa in patients on maintenance hemodialysis. Guvel, S., Pourbagher, M.A., Torun, D., Egilmez, T., Pourbagher, A., Ozkardes, H. J. Androl. (2004)
- An overview of levodopa in the management of restless legs syndrome in a dialysis population: pharmacokinetics, clinical trials, and complications of therapy. Janzen, L., Rich, J.A., Vercaigne, L.M. The Annals of pharmacotherapy. (1999)
- Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. Grohskopf, L.A., Roth, V.R., Feikin, D.R., Arduino, M.J., Carson, L.A., Tokars, J.I., Holt, S.C., Jensen, B.J., Hoffman, R.E., Jarvis, W.R. N. Engl. J. Med. (2001)
- Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. Hanly, P.J., Pierratos, A. N. Engl. J. Med. (2001)
- Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. Brent, J., McMartin, K., Phillips, S., Burkhart, K.K., Donovan, J.W., Wells, M., Kulig, K. N. Engl. J. Med. (1999)
- Levonorgestrel-releasing intrauterine device for the treatment of menometrorrhagia in a woman on hemodialysis. Fedele, L., Gammaro, L., Bianchi, S. N. Engl. J. Med. (1999)
- Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. Dieplinger, H., Schoenfeld, P.Y., Fielding, C.J. J. Clin. Invest. (1986)
- Standardized hemodialysis prescriptions promote inadequate treatment in patients with large body mass. Ifudu, O., Mayers, J.D., Matthew, J.J., Fowler, A.M., Homel, P., Friedman, E.A. Ann. Intern. Med. (1998)
- Nosocomial transmission of delta hepatitis. Lettau, L.A., Alfred, H.J., Glew, R.H., Fields, H.A., Alter, M.J., Meyer, R., Hadler, S.C., Maynard, J.E. Ann. Intern. Med. (1986)
- Renal transplantation in multiple myeloma. A case report. Humphrey, R.L., Wright, J.R., Zachary, J.B., Sterioff, S., DeFronzo, R.A. Ann. Intern. Med. (1975)
- Propranolol, epinephrine, and accelerated hypertension during hemodialysis. Whelan, T.V. Ann. Intern. Med. (1987)
- Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis. Peterson, C.D., Collins, A.J., Himes, J.M., Bullock, M.L., Keane, W.F. N. Engl. J. Med. (1981)
- Generation of dimethylnitrosamine in water purification systems. Detection in human blood samples during hemodialysis. Simenhoff, M.L., Dunn, S.R., Fiddler, W., Pensabene, J.W., Smiley, J. JAMA (1983)
- X region deletion mutants associated with surface antigen-positive hepatitis B virus infections. Feitelson, M.A., Duan, L.X., Guo, J., Blumberg, B.S. Gastroenterology (1995)
- Increased nitric oxide production in patients with hypotension during hemodialysis. Yokokawa, K., Mankus, R., Saklayen, M.G., Kohno, M., Yasunari, K., Minami, M., Kano, H., Horio, T., Takeda, T., Mandel, A.K. Ann. Intern. Med. (1995)
- Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis. Altmann, P., Al-Salihi, F., Butter, K., Cutler, P., Blair, J., Leeming, R., Cunningham, J., Marsh, F. N. Engl. J. Med. (1987)
- Granulocyte adherence changes induced by hemodialysis, endotoxin, epinephrine, and glucocorticoids. Mac Gregor, R.R. Ann. Intern. Med. (1977)
- Neutrophil adhesiveness during prostacyclin and heparin hemodialysis. Spagnuolo, P.J., Bass, S.H., Smith, M.C., Danviriyasup, K., Dunn, M.J. Blood (1982)
- Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage. Oldfield, E.H., Clark, W.C., Dedrick, R.L., Egorin, M.J., Austin, H.A., DeVroom, H.D., Joyce, K.M., Doppman, J.L. Cancer Res. (1987)
- Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Tomiya, T., Nagoshi, S., Fujiwara, K. Hepatology (1992)
- Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. Zusman, R.M., Rubin, R.H., Cato, A.E., Cocchetto, D.M., Crow, J.W., Tolkoff-Rubin, N. N. Engl. J. Med. (1981)
- The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. Owen, W.F., Lew, N.L., Liu, Y., Lowrie, E.G., Lazarus, J.M. N. Engl. J. Med. (1993)
- Advanced glycosylation end products in patients with diabetic nephropathy. Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E.A., Cerami, A., Vlassara, H. N. Engl. J. Med. (1991)
- Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis. Rapoport, J., Aviram, M., Chaimovitz, C., Brook, J.G. N. Engl. J. Med. (1978)
- Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. Pinnick, R.V., Wiegmann, T.B., Diederich, D.A. N. Engl. J. Med. (1983)
- The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients. Akagi, S., Ichikawa, H., Okada, T., Sarai, A., Sugimoto, T., Morimoto, H., Kihara, T., Yano, A., Nakao, K., Nagake, Y., Wada, J., Makino, H. J. Am. Soc. Nephrol. (2004)
- Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. Segarra, A., Chacón, P., Martinez-Eyarre, C., Argelaguer, X., Vila, J., Ruiz, P., Fort, J., Bartolomé, J., Camps, J., Moliner, E., Pelegrí, A., Marco, F., Olmos, A., Piera, L. J. Am. Soc. Nephrol. (2001)
- Lipopolysaccharide-binding protein and bactericidal/permeability-increasing factor during hemodialysis: clinical determinants and role of different membranes. Sundaram, S., King, A.J., Pereira, B.J. J. Am. Soc. Nephrol. (1997)
- The effects of corticotropin and growth hormone releasing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin. Ramirez, G., Bittle, P.A., Sanders, H., Rabb, H.A., Bercu, B.B. J. Clin. Endocrinol. Metab. (1994)
- Is blood urea nitrogen as good a guide for hemofiltration as for hemodialysis? De Fremont, J.F., Coevoet, B., Dkhissi, H., Pruna, A., Moriniere, P., Galy, C., Fournier, A. N. Engl. J. Med. (1982)
- Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. Rao, D.S., Shih, M.S., Mohini, R. N. Engl. J. Med. (1993)
- Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis. Vincenti, F., Hattner, R., Amend, W.J., Feduska, N.J., Duca, R.M., Salvatierra, O. JAMA (1981)
- Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Yasuda, K., Okuda, K., Endo, N., Ishiwatari, Y., Ikeda, R., Hayashi, H., Yokozeki, K., Kobayashi, S., Irie, Y. Gastroenterology (1995)